Early Hospital Readmission (EHR) in kidney transplantation: a review article

Early hospital readmission (EHR), defined as all readmissions within 30 days of initial hospital discharge, is a health care quality measure. It is influenced by the demographic characteristics of the population at risk, the multidisciplinary approach for hospital discharge, the access, coverage, an...

Full description

Saved in:
Bibliographic Details
Published inBrazilian Journal of Nephrology Vol. 42; no. 2; pp. 231 - 237
Main Authors Tavares, Melissa Gaspar, Tedesco-Silva Junior, Helio, Pestana, Jose Osmar Medina
Format Journal Article
LanguageEnglish
Published Brazil Sociedade Brasileira de Nefrologia 01.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Early hospital readmission (EHR), defined as all readmissions within 30 days of initial hospital discharge, is a health care quality measure. It is influenced by the demographic characteristics of the population at risk, the multidisciplinary approach for hospital discharge, the access, coverage, and comprehensiveness of the health care system, and reimbursement policies. EHR is associated with higher morbidity, mortality, and increased health care costs. Monitoring EHR enables the identification of hospital and outpatient healthcare weaknesses and the implementation of corrective interventions. Among kidney transplant recipients in the USA, EHR ranges between 18 and 47%, and is associated with one-year increased mortality and graft loss. One study in Brazil showed an incidence of 19.8% of EHR. The main causes of readmission were infections and surgical and metabolic complications. Strategies to reduce early hospital readmission are therefore essential and should consider the local factors, including socio-economic conditions, epidemiology and endemic diseases, and mobility.
Bibliography:The authors declare that they have no conflict of interest related to the publication of this manuscript.
Melissa Gaspar Tavares, Helio Tedesco-Silva Junior, and Jose Osmar Medina Pestana contributed substantially to the conception or design of the study; collection, analysis, or interpretation of data; writing or critical review of the manuscript; and final approval of the version to be published.
Author’s contribution
Conflict of interest
ISSN:0101-2800
2175-8239
DOI:10.1590/2175-8239-JBN-2019-0089